{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:10:32Z","timestamp":1778821832312,"version":"3.51.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a bodywide inflammatory condition that produces additional symptoms outside the joints that make the disease more severe and lead to patient disability and death. This research investigated various factors associated with the presence of extra-articular manifestations in RA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The cross-sectional study was conducted from 2023 to 2025 and assessed 299 adult patients who received RA confirmation. Clinical assessments, laboratory tests, and instrumental results were evaluated for extra-articular manifestations, and univariable and multivariable logistic regression analyses were performed to examine these relationships. Results: Extra-articular manifestations were present in 278 patients (93%). Patients with extra-articular manifestations were older (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.039) and more frequently had disability (76% vs. 48%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.004). They also demonstrated higher levels of systemic inflammation, including C-reactive protein (median 20 vs. 11 mg\/L,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.015), erythrocyte sedimentation rate (36 vs. 21 mm\/h,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), rheumatic factor (92 vs. 55.2 IU\/mL,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), and higher antinuclear antibodies index values (1.5 vs. 0.43,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.023). In the multivariable model, ESR remained independently associated with extra-articular manifestations (adjusted OR = 1.18,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001), while elevated white blood cell count was inversely associated (adjusted OR = 0.07,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). Conclusions: Extra-articular manifestations in rheumatoid arthritis are most strongly associated with sustained systemic inflammation, as reflected by ESR, underscoring the importance of monitoring chronic inflammatory burden and the need for longitudinal studies to clarify causality and therapeutic implications.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1814238","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:26:39Z","timestamp":1778819199000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic inflammation and extra-articular manifestations in rheumatoid arthritis: a cross-sectional study"],"prefix":"10.3389","volume":"13","author":[{"given":"Karlygash","family":"Sadykova","sequence":"first","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulnaz","family":"Nuskabayeva","sequence":"additional","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainash","family":"Oshibayeva","sequence":"additional","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakhnoza","family":"Tatykayeva","sequence":"additional","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmira","family":"Iskandirova","sequence":"additional","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Mamutova","sequence":"additional","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziza","family":"Djurabekova","sequence":"additional","affiliation":[{"name":"Samarkand State Medical University","place":["Samarkand, Uzbekistan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugilzhan","family":"Tatykayeva","sequence":"additional","affiliation":[{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University","place":["Turkistan, Kazakhstan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities.","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4081\/reumatismo.2018.1106","article-title":"Extra-articular rheumatoid arthritis.","volume":"70","author":"Marcucci","year":"2018","journal-title":"Reumatismo."},{"key":"B3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s42358-023-00318-y","article-title":"Extra-articular manifestations of rheumatoid arthritis remain a major challenge: data from a large, multi-centric cohort.","volume":"63","author":"Bonfiglioli","year":"2023","journal-title":"Adv Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"102735","DOI":"10.1016\/j.autrev.2020.102735","article-title":"Beyond the joints, the extra-articular manifestations in rheumatoid arthritis.","volume":"20","author":"Conforti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.25231","article-title":"Decline in incidence of extra-articular manifestations of rheumatoid arthritis: a population-based cohort study.","volume":"76","author":"Kimbrough","year":"2024","journal-title":"Arthritis Care Res"},{"key":"B6","unstructured":"Turdalin\n              N\n            \n            \n              Gabdulina\n              G\n            \n            \n              Aubakirova\n              B\n            \n            \n              Amanzholova\n              A\n            \n            \n              Smagulova\n              G.\n            \n          \n          Rheumatoid Arthritis. Version: Clinical Protocols of the Ministry of Health of the Republic of Kazakhstan - 2016 [Internet].\n          \n          2016"},{"key":"B7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1515\/med-2020-0217","article-title":"Influence factors of extra-articular manifestations in rheumatoid arthritis.","volume":"15","author":"Chen","year":"2020","journal-title":"Open Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/iid3.514","article-title":"Extra-articular involvement of rheumatoid arthritis in three seropositive patients in the absence of initial joint involvement.","volume":"9","author":"Chirila","year":"2021","journal-title":"Immun Inflamm Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejim.2024.04.026","article-title":"Incidence and predisposing factors of extra-articular manifestations in contemporary rheumatoid arthritis.","volume":"126","author":"Ljung","year":"2024","journal-title":"Eur J Intern Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","article-title":"C-reactive protein and implications in rheumatoid arthritis and associated comorbidities.","volume":"51","author":"Pope","year":"2021","journal-title":"Semin Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e003789","DOI":"10.1136\/rmdopen-2023-003789","article-title":"Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT register.","volume":"10","author":"Rudi","year":"2024","journal-title":"RMD Open."},{"key":"B12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.13107\/jocr.2025.v15.i04.5526","article-title":"Effect of DMARD therapy on inflammatory biomarkers and disease activity in rheumatoid arthritis patients.","volume":"15","author":"Kharbanda","year":"2025","journal-title":"J Orthop Case Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1093\/rheumatology\/kead083","article-title":"Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application.","volume":"62","author":"Barbulescu","year":"2023","journal-title":"Rheumatology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/biomedicines11051262","article-title":"Pathogenesis of extraarticular manifestations in rheumatoid arthritis-a comprehensive review.","volume":"11","author":"Mitrovi\u00e6","year":"2023","journal-title":"Biomedicines"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1505615","DOI":"10.3389\/fimmu.2024.1505615","article-title":"High cumulative glucocorticoid dose is associated with increased levels of inflammation-related mediators in active rheumatoid arthritis.","volume":"15","author":"Petrackova","year":"2024","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00124743-199608000-00007","article-title":"Leukocytosis in rheumatoid arthritis.","volume":"2","author":"Syed","year":"1996","journal-title":"J Clin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/0256-4947.51774","article-title":"Extra-articular manifestations of rheumatoid arthritis: a hospital-based study.","volume":"29","author":"Al-Ghamdi","year":"2009","journal-title":"Ann Saudi Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s40744-021-00310-2","article-title":"Association between baseline anti-cyclic citrullinated peptide antibodies and 6-month clinical response following abatacept or TNF inhibitor treatment: a real-world analysis of biologic-experienced patients with RA.","volume":"8","author":"Harrold","year":"2021","journal-title":"Rheumatol Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.70749\/ijbr.v3i7.2015","article-title":"The association of anti-cyclic citrullinated peptide positivity with extra-articular manifestations in patients with rheumatoid arthritis.","volume":"3","author":"Muhammad","year":"2025","journal-title":"IJBR."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments.","volume":"23","author":"Maeda","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/biom12101383","article-title":"Calcium-permeable channels cooperation for rheumatoid arthritis: therapeutic opportunities.","volume":"12","author":"Liang","year":"2022","journal-title":"Biomolecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41927-023-00325-y","article-title":"Vitamin D status and risk of rheumatoid arthritis: systematic review and meta-analysis.","volume":"7","author":"Clasen","year":"2023","journal-title":"BMC Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"152921","DOI":"10.1016\/j.semarthrit.2026.152921","article-title":"Risk of ILD and safety outcomes across DMARD classes in rheumatoid arthritis and RA-ILD.","volume":"77","author":"Lee","year":"2026","journal-title":"Semin Arthritis Rheum"},{"key":"B24","doi-asserted-by":"publisher","first-page":"152580","DOI":"10.1016\/j.semarthrit.2024.152580","article-title":"The veterans affairs rheumatoid arthritis registry: a unique population in rheumatoid arthritis research.","author":"Mikuls","year":"2025","journal-title":"Semin Arthritis Rheum."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1814238\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:26:42Z","timestamp":1778819202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1814238\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":24,"alternative-id":["10.3389\/fmed.2026.1814238"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1814238","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1814238"}}